Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Buy” by Analysts
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has been assigned a consensus rating of “Buy” from the ten research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and three have given a strong buy rating to […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has been assigned a consensus rating of “Buy” from the ten research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and three have given a strong buy rating to […]